Patent · US Active

Bendamustine derivatives and methods of using same

US9630926B2 · kind B2 · utility

0Cited by

22References

18Claims

0Family size

Assignee

Ignyta, Inc. · US

Inventors

Roger P. Bakale · Summit, US
Peter D. Brown · West Chester, US
Jian Chen · Camarillo, US
Anthony S. Drager · Midland, US
Rachel Y. LaBell · Coatesville, US
Robert E. McKean · Chester Springs, US
Piyush R. Patel · Wallingford, US
Renee Caroline Roemmele · Masontown, US

Key dates

Filing date	Jun 16, 2016
Grant date	Apr 25, 2017
Priority date	—
Expiry date	Jun 16, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D235/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.